Fund Holdings — Trails Edge Capital Partners, LP

Total Portfolio Value:
$695.90M
Total Bought:
$695.90M
Total Sold:
$0
Net Transaction:
+$695.90M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
LB Pharmaceuticals Inc(LBRX)01,149,240+1,149,240$0$44.11M6.34%+$44.11M
BioMarin Pharmaceutical Inc.(BMRN)0667,000+667,000$0$40.02M5.75%+$40.02M
Nurix Therapeutics, Inc.(NRIX)01,573,220+1,573,220$0$37.30M5.36%+$37.30M
Obsidian Therapeutics Inc02,495,660+2,495,660$0$34.27M4.92%+$34.27M
Immunocore Holdings plcADS(IMCR)01,063,234+1,063,234$0$32.21M4.63%+$32.21M
4d Molecular Therapeutics In02,227,917+2,227,917$0$31.88M4.58%+$31.88M
Design Therapeutics Inc02,500,000+2,500,000$0$31.43M4.52%+$31.43M
Cytokinetics, Incorporated(CYTK)0470,000+470,000$0$30.98M4.45%+$30.98M
First Tracks Biotherapeutics, Inc.(TRAX)0814,000+814,000$0$28.85M4.15%+$28.85M
Faeth Therapeutics Inc0941,689+941,689$0$28.01M4.02%+$28.01M
Tango Therapeutics, Inc.(TNGX)01,100,000+1,100,000$0$27.45M3.94%+$27.45M
Neurogene Inc0964,885+964,885$0$26.84M3.86%+$26.84M
Celldex Therapeutics, Inc.(CLDX)0765,000+765,000$0$24.79M3.56%+$24.79M
Avalo Therapeutics Inc01,500,000+1,500,000$0$23.00M3.30%+$23.00M
Contineum Therapeutics IncCL A01,693,694+1,693,694$0$22.73M3.27%+$22.73M
Tyra Biosciences, Inc.(TYRA)01,000,000+1,000,000$0$21.87M3.14%+$21.87M
MoonLake ImmunotherapeuticsCL A(MLTX)01,680,000+1,680,000$0$19.66M2.82%+$19.66M
Inhibikase Therapeutics Inc09,110,112+9,110,112$0$18.72M2.69%+$18.72M
Inhibrx Biosciences, Inc.(INBX)0170,000+170,000$0$17.01M2.44%+$17.01M
Xenon Pharmaceuticals Inc.(XENE)0400,000+400,000$0$14.88M2.14%+$14.88M
Camp4 Therapeutics Corp03,625,576+3,625,576$0$14.65M2.10%+$14.65M
Altimmune Inc04,230,000+4,230,000$0$12.10M1.74%+$12.10M
Opus Genetics Inc02,411,657+2,411,657$0$11.67M1.68%+$11.67M
Kailera Therapeutics, Inc.(KLRA)0942,953+942,953$0$10.77M1.55%+$10.77M
Sol-Gel Technologies LtdSHS NEW0139,445+139,445$0$10.36M1.49%+$10.36M
Inventiva SaADS02,657,997+2,657,997$0$9.81M1.41%+$9.81M
Entrada Therapeutics Inc01,428,440+1,428,440$0$9.07M1.30%+$9.07M
Aura Biosciences Inc01,443,333+1,443,333$0$9.06M1.30%+$9.06M
Research Alliance Corp IiiCL A
ORD SHS CL A
0822,500+822,500$0$8.91M1.28%+$8.91M
X4 Pharmaceuticals Inc02,571,478+2,571,478$0$7.46M1.07%+$7.46M
Century Therapeutics Inc04,134,969+4,134,969$0$7.07M1.02%+$7.07M
Promis Neurosciences Inc0557,103+557,103$0$6.04M0.87%+$6.04M
Research Alliance Corp IvCL A0500,000+500,000$0$6.00M0.86%+$6.00M
Imagenebio Inc01,094,045+1,094,045$0$5.01M0.72%+$5.01M
Minerva Neurosciences Inc01,419,000+1,419,000$0$4.75M0.68%+$4.75M
Tcgx Acquisition CorpCL A0250,000+250,000$0$3.13M0.45%+$3.13M
Vtv Therapeutics IncCL A076,989+76,989$0$2.37M0.34%+$2.37M
Onkure Therapeutics IncCL A0619,557+619,557$0$1.69M0.24%+$1.69M
Page 1 of 1